Article ID Journal Published Year Pages File Type
6006492 Clinical Neurology and Neurosurgery 2014 5 Pages PDF
Abstract
Only 20% of patients with residual tumor developed recurrent disease over a median follow up of 23.1 months. This recurrence rate may be an important consideration in cases where gross total resection is not feasible. Preferentially operating from the right does not seem to influence the location of residual tumor.
Related Topics
Life Sciences Neuroscience Neurology
Authors
, , , , , , ,